Mark Wills

7PUBLICATIONS
29CO-AUTHORS
Innate immunityPredictive and prognostic markersHaematological tumoursTissue engineeringElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 06, 2025
The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment.

Sarah Elizabeth Jackson, Mahlaqua Noor, Eleanor Lim

|Feb 21, 2024
Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to Long Covid.

Benjamin A Krishna, Eleanor Y Lim, Marina Metaxaki

|Feb 23, 2021
Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.

Ian J Groves, Sarah E Jackson, Emma L Poole

|Apr 14, 2020
Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner.

Liling Shan, Shuang Li, Jan Meeldijk

|Mar 22, 2019
Generation, maintenance and tissue distribution of T cell responses to human cytomegalovirus in lytic and latent infection.

Sarah E Jackson, George X Sedikides, Georgina Okecha

|Sep 15, 2018
Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.

F Tudor Ilca, Andreas Neerincx, Mark R Wills

Pageof 2

Frequent Collaborators

5 joint publications

Sarah Jackson

2 joint publications

Ian J Groves

2 joint publications

John Sinclair

1 joint publications

F Tudor Ilca